QualiCode™ HIV-1/2 Western Blot Kit
US: For Research Use Only. Not For Use in Diagnostic Procedures.
Catalog # DK-C152-024
Overview
AIDS (Acquired Immunodeficiency Syndrome), caused by infection with Human Immunodeficiency Virus (HIV), continues a deadly and insidious disease. Two types of HIV have been identified: HIV-1 is responsible for the majority of infections worldwide, while HIV-2 is relatively uncommon but likewise pathogenic. Patients with AIDS and AIDS related diseases typically develop a detectable antibody response to the HIV-1 or HIV-2 virus. Because of the potential for false positive results in HIV screening tests, the Western Blot has been established by CDC and other public health organizations as a confirmatory test for HIV antibodies. The Western Blot shows the reactivity of antibodies with individual HIV viral antigens, and makes it possible to distinguish true infection from a spurious immune response to cross-reactive non-HIV antigens. Such spurious responses are known to occur in the general population at a low frequency. The pattern of antigen reactivity on HIV Western Blot is also useful in monitoring the stage of infection and detecting seroconversion in recently infected individuals. Immunetics’ QualiCode HIV-1/2 Western Blot Kit provides an effective solution to confirmatory testing for HIV antibodies. The kit combines HIV-1 viral lysate antigens and a separate HIV-2 antigen, enabling detection of both HIV-1 and HIV-2 antibodies on a single test strip.
· Effective: For detection of antibodies to HIV-1 and HIV-2 in human serum or plasma. Each assay strip includes HIV-1 antigens from viral lysate and an HIV-2 recombinant protein.
· Easy to use: Each strip includes an internal control band to assure proper sample and reagent addition and valid test results. Each kit contains a lot-specific reference card for identification of bands on test strips. Each kit contains positive, negative and weakly reactive controls.
· Fast turnaround: Test results under 3 hours.
· Proven: Manufactured under licenser from the National Institutes of Health.